WallStreetZenWallStreetZen

NYSE: PACS
Pacs Group Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for PACS

Based on 4 analysts offering 12 month price targets for Pacs Group Inc

Min Forecast
$18.00+94.38%
Avg Forecast
$26.25+183.48%
Max Forecast
$32.00+245.57%

Should I buy or sell PACS stock?

Based on 4 analysts offering ratings for Pacs Group Inc.

Strong Buy
Strong Buy
2 analysts 50%
Buy
1 analysts 25%
Hold
1 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although PACS's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates PACS as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their PACS stock forecasts and price targets.

PACS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-01-06
lockedlocked$00.00+00.00%2025-01-06
lockedlocked$00.00+00.00%2024-12-17
lockedlocked$00.00+00.00%2024-11-18

1 of 1

Forecast return on equity

Is PACS forecast to generate an efficient return?

Company
57%
Industry
-64.32%
Market
76.12%
PACS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PACS forecast to generate an efficient return on assets?

Company
8.37%
Industry
8.84%
PACS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PACS earnings per share forecast

What is PACS's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$1.82
Avg 2 year Forecast
$2.14

PACS revenue forecast

What is PACS's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$4.4B
Avg 2 year Forecast
$4.9B

PACS vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
PACS$9.26$26.25+183.48%Strong Buy
NHC$92.13N/AN/A
GRDN$24.11$23.00-4.60%Strong Buy
BKD$6.24$7.83+25.53%Buy
AGL$4.00$3.78-5.63%Hold
View Top Medical Care Facility Stocks

Pacs Group Stock Forecast FAQ

Is Pacs Group Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NYSE: PACS) stock is to Strong Buy PACS stock.

Out of 4 analysts, 2 (50%) are recommending PACS as a Strong Buy, 1 (25%) are recommending PACS as a Buy, 1 (25%) are recommending PACS as a Hold, 0 (0%) are recommending PACS as a Sell, and 0 (0%) are recommending PACS as a Strong Sell.

If you're new to stock investing, here's how to buy Pacs Group stock.

What is PACS's earnings growth forecast for 2025-2026?

(NYSE: PACS) Pacs Group's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 18.64%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 70.58%.

Pacs Group's earnings in 2025 is N/A.On average, 1 Wall Street analyst forecast PACS's earnings for 2025 to be $277,367,514, with the lowest PACS earnings forecast at $277,367,514, and the highest PACS earnings forecast at $277,367,514.

In 2026, PACS is forecast to generate $326,135,429 in earnings, with the lowest earnings forecast at $326,135,429 and the highest earnings forecast at $326,135,429.

What is PACS's revenue growth forecast for 2025-2026?

(NYSE: PACS) Pacs Group's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 6.31%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.36%.

Pacs Group's revenue in 2025 is N/A.On average, 1 Wall Street analysts forecast PACS's revenue for 2025 to be $677,874,012,384, with the lowest PACS revenue forecast at $677,874,012,384, and the highest PACS revenue forecast at $677,874,012,384.

In 2026, PACS is forecast to generate $747,063,491,166 in revenue, with the lowest revenue forecast at $747,063,491,166 and the highest revenue forecast at $747,063,491,166.

What is PACS's forecast return on assets (ROA) for 2025-2026?

(NYSE: PACS) forecast ROA is 8.37%, which is lower than the forecast US Medical Care Facilities industry average of 8.84%.

What is PACS's Price Target?

According to 4 Wall Street analysts that have issued a 1 year PACS price target, the average PACS price target is $26.25, with the highest PACS stock price forecast at $32.00 and the lowest PACS stock price forecast at $18.00.

On average, Wall Street analysts predict that Pacs Group's share price could reach $26.25 by Jan 6, 2026. The average Pacs Group stock price prediction forecasts a potential upside of 183.48% from the current PACS share price of $9.26.

What is PACS's Earnings Per Share (EPS) forecast for 2025-2026?

(NYSE: PACS) Pacs Group's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that PACS's EPS will be $1.82 for 2025, with the lowest EPS forecast at $1.82, and the highest EPS forecast at $1.82. In 2026, PACS's EPS is forecast to hit $2.14 (min: $2.14, max: $2.14).

What is PACS's forecast return on equity (ROE) for 2025-2026?

(NYSE: PACS) forecast ROE is 57%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.